pharmaceutical administration form comprising 5-chloro-n - ({(5s) -2-oxo-3 - [4- (3-oxo-4-morpholinyl) phenyl] -1,3-oxazolidine-5-yl} - methyl - 2 - thiophenecarboxamide

• 收藏
• 分享

专利权人:

BAYER PHARMA AKTIENGESELLSCHAFT

发明人:

HEIKE NEUMANN,KLAUS BENKE,WOLFGANG MÜCK

申请号：

BR112015000043

公开号：

BR112015000043A2

申请日:

2013.06.28

申请国别(地区):

BR

年份:

2017

代理人:

摘要：

The present invention relates to solid orally administrable pharmaceutical administration forms comprising 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide (rivaroxaban, active compound (I)), wherein a partial amount of the active compound (I) is released rapidly and a partial amount is released in a controlled manner (modified, retarded, delayed), and to processes for their preparation, their use as medicaments and their use for the prophylaxis, secondary prophylaxis or treatment of disorders.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/